查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1697924

全球神經可塑性增強設備市場：市場規模、佔有率、趨勢、產業分析（按產品類型、應用、最終用戶和地區）、未來預測（2025-2034）

Neuroplasticity Enhancement Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，全球神經可塑性增強設備市場預計到 2034 年將達到 714 億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

神經可塑性，即大腦透過形成新的神經連結來重組自身的能力，已成為神經科學、認知科學和醫學研究的重點。最近的趨勢是，技術進步推動了神經可塑性增強設備的發展，旨在優化大腦功能、促進學習、幫助康復，甚至增強超越自然極限的認知能力。這些設備使用多種技術，包括電刺激和磁刺激、腦波調節、神經反饋和感覺增強，來誘導神經可塑性變化。

經顱磁刺激 (TMS) 是一種廣泛使用的設備，它利用磁場在大腦中感應電流，促進神經重組。TMS 已被批准用於治療憂鬱症，並且還被證明可有效治療其他神經系統疾病，包括帕金森氏症和慢性疼痛。

這些設備允許用戶即時監控和調整他們的大腦活動。基於腦電圖 (EEG) 的神經回饋設備追蹤腦電波模式並透過視覺、聽覺或觸覺提示提供回饋，以幫助使用者訓練大腦活動達到所需狀態。腦機介面（BCI）在增強神經可塑性方面也發揮著重要作用。BCI 對癱瘓和神經退化性疾病患者俱有特別大的改變作用，使他們能夠重新獲得功能獨立性。

神經可塑性增強設備市場：分析概述

根據產品類型，經顱磁刺激 (TMS) 設備佔據了 2024 年神經可塑性增強設備市場的最大佔有率，這歸功於其在治療神經和精神疾病方面的有效性。

從最終用戶來看，隨著個人尋求方便且經濟高效的認知增強和神經復健解決方案，家庭醫療保健領域預計將在未來幾年佔據主導地位。

2024 年，北美憑藉其強大的醫療保健基礎設施、先進神經技術的高採用率以及神經系統疾病的日益流行，佔據了全球神經可塑性增強設備市場的收入佔有率。

由於城市化進程加快、醫療保健支出增加以及大腦意識增強，預計未來幾年亞太市場將會成長。

一些世界領先的公司包括 BioSerenity、Blackrock Neurotech、BrainCo、BrainsWay、Ceribell、EMOTIV、Flow Neuroscience、Neurable、Neuralink、NeuroPace、Paradromics 和 Synchron。

目錄

第1章 引言

第2章 執行摘要

第3章分析方法

第4章全球神經可塑性增強設備市場洞察

  • 市場快照
  • 神經可塑性增強設備的市場動態
    • 推動因素和機遇
      • 全球老齡人口正在增加
      • 年輕人憂鬱症盛行率不斷上升
    • 阻礙因素和課題
      • 成本高、認知度低
  • PESTLE 分析
  • 神經可塑性增強設備市場趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第5章全球神經可塑性增強設備市場（按產品類型）

  • 主要發現
  • 介紹
  • 經顱磁刺激（TMS）裝置
  • 經顱直流電刺激（tDCS）裝置
  • 基於腦電圖（EEG）的設備
  • 其他

第6章 全球神經可塑性增強設備市場（依應用）

  • 主要發現
  • 介紹
  • 提升認知能力
  • 中風和腦外傷康復
  • 精神健康與神經系統疾病
  • 提升學習和記憶力
  • 其他

第7章 全球神經可塑性增強設備市場（依最終用戶）

  • 主要發現
  • 介紹
  • 醫院/診所
  • 研究機構和學術中心
  • 家庭醫療
  • 其他

第8章 全球神經可塑性增強設備市場（按地區）

  • 主要發現
  • 介紹
    • 神經可塑性增強設備市場（按地區）分析（2020-2034）
  • 北美
    • 北美：依產品類型（2020-2034 年）
    • 北美應用情形（2020-2034）
    • 北美：按最終用戶劃分（2020-2034 年）
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依產品類型（2020-2034 年）
    • 歐洲：按應用劃分（2020-2034 年）
    • 歐洲：依最終用戶劃分（2020-2034 年）
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 歐洲其他地區
  • 亞太地區
    • 亞太地區產品類型（2020-2034）
    • 亞太地區應用情況（2020-2034）
    • 亞太地區最終用戶分佈（2020-2034）
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東/非洲
    • 中東和非洲：按產品類型（2020-2034 年）
    • 中東和非洲的應用（2020-2034）
    • 中東和非洲：按最終用戶劃分（2020-2034 年）
    • 沙烏地阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 南非
    • 其他中東/非洲
  • 拉丁美洲
    • 2020-2034 年拉丁美洲產品類型
    • 拉丁美洲應用情況（2020-2034）
    • 拉丁美洲最終用戶分佈（2020-2034）
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲

第9章競爭格局

  • 業務擴展和收購分析
    • 業務拓展
    • 收購
  • 夥伴關係/協作/協議/揭露

第10章 公司簡介

  • BioSerenity
  • Blackrock Neurotech
  • BrainCo Inc.
  • BrainsWay
  • Ceribell, Inc.
  • EMOTIV
  • Flow Neuroscience
  • Neurable
  • Neuralink
  • NeuroPace, Inc.
  • Paradromics
  • Synchron
Product Code: PM5416

The global neuroplasticity enhancement devices market size is expected to reach USD 71.40 billion by 2034, according to a new study by Polaris Market Research. The report "Neuroplasticity Enhancement Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type [Transcranial Magnetic Stimulation (TMS) Devices, Transcranial Direct Current Stimulation (tDCS) Devices, Electroencephalogram (EEG)-Based Devices, and Others], Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Neuroplasticity, the brain's ability to reorganize itself by forming new neural connections, has been a major focus in neuroscience, cognitive science, and medical research. In recent years, advancements in technology have led to the development of neuroplasticity enhancement devices, which aim to optimize brain function, accelerate learning, aid in rehabilitation, and even enhance cognitive abilities beyond natural limits. These devices use a variety of techniques, including electrical and magnetic stimulation, brainwave modulation, neurofeedback, and sensory augmentation, to encourage neuroplastic changes.

Transcranial magnetic stimulation (TMS) is a widely used device that employs magnetic fields to induce electric currents in the brain, facilitating neural reorganization. TMS has been approved for treating depression and has shown effectiveness in treating other neurological disorders, such as Parkinson's disease and chronic pain conditions.

These device allow users to monitor and regulate their brain activity in real time, providing a form of self-directed neuroplasticity training. Electroencephalography (EEG)-based neurofeedback devices track brainwave patterns and provide feedback through visual, auditory, or haptic cues, helping users train their brain activity toward desired states. Brain-computer interfaces (BCIs) are also playing a crucial role in neuroplasticity enhancement. BCIs have been particularly transformative for individuals affected by paralysis or neurodegenerative conditions, enabling them to regain functional independence.

Neuroplasticity Enhancement Devices Market Report Highlights

In terms of product type, the transcranial magnetic stimulation (TMS) devices segment held the largest neuroplasticity enhancement devices market share in 2024 due to their proven effectiveness in treating neurological and psychiatric disorders.

Based on end user, the home care settings segment is projected to hold a dominant share in the coming years as individuals seek convenient, cost-effective solutions for cognitive enhancement and neurological rehabilitation.

North America dominated the global neuroplasticity enhancement devices market revenue share in 2024 due to its strong healthcare infrastructure, high adoption of advanced neurotechnology, and increasing prevalence of neurological disorders.

The market in Asia Pacific is expected to grow in the coming years, owing to rapid urbanization, increasing healthcare expenditures, and growing awareness of the brain.

A few of the global key market players are BioSerenity; Blackrock Neurotech; BrainCo Inc.; BrainsWay; Ceribell, Inc.; EMOTIV; Flow Neuroscience; Neurable; Neuralink; NeuroPace, Inc.; Paradromics; and Synchron.

Polaris Market Research has segmented the neuroplasticity enhancement devices market report on the basis of product type, application, end user, and region:

By Product Type Outlook (Revenue, USD Billion, 2020-2034)

  • Transcranial Magnetic Stimulation (TMS) Devices
  • Transcranial Direct Current Stimulation (tDCS) Devices
  • Electroencephalogram (EEG)-Based Devices
  • Others

By Application Mode Outlook (Revenue, USD Billion, 2020-2034)

  • Cognitive Enhancement
  • Stroke & Traumatic Brain Injury Recovery
  • Mental Health & Neurological Disorders
  • Learning & Memory Improvement
  • Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

  • Hospitals & Clinics
  • Research Institutions & Academic Centers
  • Home Care Settings
  • Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Neuroplasticity Enhancement Devices Market Insights

  • 4.1. Neuroplasticity Enhancement Devices Market - Market Snapshot
  • 4.2. Neuroplasticity Enhancement Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Geriatric Population Globally
      • 4.2.1.2. Growing Prevalence of Depression Among Young Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and lack of awareness
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Neuroplasticity Enhancement Devices Market Trends
  • 4.6. Value Chain Analysis

5. Global Neuroplasticity Enhancement Devices Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • 5.3. Transcranial Magnetic Stimulation (TMS) Devices
    • 5.3.1. Global Neuroplasticity Enhancement Devices Market, by Transcranial Magnetic Stimulation (TMS) Devices, by Region, 2020-2034 (USD Billion)
  • 5.4. Transcranial Direct Current Stimulation (tDCS) Devices
    • 5.4.1. Global Neuroplasticity Enhancement Devices Market, by Transcranial Direct Current Stimulation (tDCS) Devices, by Region, 2020-2034 (USD Billion)
  • 5.5. Electroencephalogram (EEG)-Based Devices
    • 5.5.1. Global Neuroplasticity Enhancement Devices Market, by Electroencephalogram (EEG)-Based Devices, by Region, 2020-2034 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Neuroplasticity Enhancement Devices Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Cognitive Enhancement
    • 6.3.1. Global Neuroplasticity Enhancement Devices Market, by Cognitive Enhancement, by Region, 2020-2034 (USD Billion)
  • 6.4. Stroke & Traumatic Brain Injury Recovery
    • 6.4.1. Global Neuroplasticity Enhancement Devices Market, by Stroke & Traumatic Brain Injury Recovery, by Region, 2020-2034 (USD Billion)
  • 6.5. Mental Health & Neurological Disorders
    • 6.5.1. Global Neuroplasticity Enhancement Devices Market, by Mental Health & Neurological Disorders, by Region, 2020-2034 (USD Billion)
  • 6.6. Learning & Memory Improvement
    • 6.6.1. Global Neuroplasticity Enhancement Devices Market, by Learning & Memory Improvement, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Neuroplasticity Enhancement Devices Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Global Neuroplasticity Enhancement Devices Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
  • 7.4. Research Institutions & Academic Centers
    • 7.4.1. Global Neuroplasticity Enhancement Devices Market, by Research Institutions & Academic Centers, by Region, 2020-2034 (USD Billion)
  • 7.5. Home Care Settings
    • 7.5.1. Global Neuroplasticity Enhancement Devices Market, by Home Care Settings, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Neuroplasticity Enhancement Devices Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Neuroplasticity Enhancement Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Neuroplasticity Enhancement Devices Market - North America
    • 8.3.1. North America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.3.4. Neuroplasticity Enhancement Devices Market - U.S.
      • 8.3.4.1. U.S.: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.3.5. Neuroplasticity Enhancement Devices Market - Canada
      • 8.3.5.1. Canada: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 8.4. Neuroplasticity Enhancement Devices Market - Europe
    • 8.4.1. Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.4. Neuroplasticity Enhancement Devices Market - UK
      • 8.4.4.1. UK: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.5. Neuroplasticity Enhancement Devices Market - France
      • 8.4.5.1. France: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.6. Neuroplasticity Enhancement Devices Market - Germany
      • 8.4.6.1. Germany: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.7. Neuroplasticity Enhancement Devices Market - Italy
      • 8.4.7.1. Italy: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.8. Neuroplasticity Enhancement Devices Market - Spain
      • 8.4.8.1. Spain: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.9. Neuroplasticity Enhancement Devices Market - Netherlands
      • 8.4.9.1. Netherlands: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.10. Neuroplasticity Enhancement Devices Market - Russia
      • 8.4.10.1. Russia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.11. Neuroplasticity Enhancement Devices Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 8.5. Neuroplasticity Enhancement Devices Market - Asia Pacific
    • 8.5.1. Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.4. Neuroplasticity Enhancement Devices Market - China
      • 8.5.4.1. China: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.5. Neuroplasticity Enhancement Devices Market - India
      • 8.5.5.1. India: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.6. Neuroplasticity Enhancement Devices Market - Malaysia
      • 8.5.6.1. Malaysia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.7. Neuroplasticity Enhancement Devices Market - Japan
      • 8.5.7.1. Japan: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.8. Neuroplasticity Enhancement Devices Market - Indonesia
      • 8.5.8.1. Indonesia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.9. Neuroplasticity Enhancement Devices Market - South Korea
      • 8.5.9.1. South Korea: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.10. Neuroplasticity Enhancement Devices Market - Australia
      • 8.5.10.1. Australia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.11. Neuroplasticity Enhancement Devices Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 8.6. Neuroplasticity Enhancement Devices Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.4. Neuroplasticity Enhancement Devices Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.5. Neuroplasticity Enhancement Devices Market - UAE
      • 8.6.5.1. UAE: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.6. Neuroplasticity Enhancement Devices Market - Israel
      • 8.6.6.1. Israel: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.7. Neuroplasticity Enhancement Devices Market - South Africa
      • 8.6.7.1. South Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.8. Neuroplasticity Enhancement Devices Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 8.7. Neuroplasticity Enhancement Devices Market - Latin America
    • 8.7.1. Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.7.4. Neuroplasticity Enhancement Devices Market - Mexico
      • 8.7.4.1. Mexico: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.7.5. Neuroplasticity Enhancement Devices Market - Brazil
      • 8.7.5.1. Brazil: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.7.6. Neuroplasticity Enhancement Devices Market - Argentina
      • 8.7.6.1. Argentina: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.7.7. Neuroplasticity Enhancement Devices Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. BioSerenity
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Blackrock Neurotech
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BrainCo Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. BrainsWay
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Ceribell, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. EMOTIV
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Flow Neuroscience
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Neurable
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Neuralink
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. NeuroPace, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Paradromics
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Synchron
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables:

  • Table 1 Global Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 2 Global Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 4 North America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 5 North America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 7 U.S.: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 10 Canada: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 13 Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 16 UK: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 17 UK: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 19 France: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 20 France: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 22 Germany: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 25 Italy: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 28 Spain: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 34 Russia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 43 China: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 44 China: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 46 India: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 47 India: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 52 Japan: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 58 South Korea: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Australia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 73 UAE: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 76 Israel: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 79 South Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 85 Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 88 Mexico: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 91 Brazil: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 94 Argentina: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Neuroplasticity Enhancement Devices Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Neuroplasticity Enhancement Devices Market, by Product Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Neuroplasticity Enhancement Devices Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End User
  • Figure 11. Global Neuroplasticity Enhancement Devices Market, by End User, 2024 & 2034 (USD Billion)